Nature communications · 2018 · Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural · PMID 29599478
All interactive lessonsChronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.
IW Interactive Learning Engine · About 5 minutes
NAD+: a biomarker is not a benefit
0 of 6 steps completedSaved privately to this browser · 90 days
Step 1 · Explore
Start with the question
Nicotinamide riboside is a precursor used to make NAD+, a molecule involved in metabolism. Raising NAD-related biomarkers does not by itself establish healthier aging or longer life. NAD+ helps cells transfer energy and supports other cellular reactions. NR can supply material for making NAD+. More of a marker is not automatically a meaningful health benefit.
Learning request limit reached. Please try again later.
Sources behind this lesson
Your scientific classroom
Ask the IW Science Instructor
Basic level · Published sources only · AI evidence check
Ask about general science. Do not enter names, personal health details or medication lists. This is not a clinical consultation. Discussion stays in this browser’s private learning session for up to 90 days.
IW Interactive Learning Engine · Adapted from stable OpenMAIC v1.2.1. Open-source license
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.